ADMA vs DFS
ADMA Biologics Inc (ADMA) versus DFS (DFS) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
DFS (DFS) common stock.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
DFS does not have a complete income-statement cache yet.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Not investment advice. Open the ADMA and DFS stock pages for the full models.
Not investment advice.